Study on Malaria Infection Factors in Pregnant Women and Children in Mali
This study is critical as it aims to uncover factors influencing malaria susceptibility in vulnerable populations, which could significantly inform vaccine development. Insights gained may lead to improved public health strategies and interventions targeting malaria in pregnant women and young children.
Phase III
Infectious Disease / Malaria
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
This study is critical as it aims to uncover factors influencing malaria susceptibility in vulnerable populations, which could significantly inform vaccine development. Insights gained may lead to improved public health strategies and interventions targeting malaria in pregnant women and young children.
Why it matters
This study is critical as it aims to uncover factors influencing malaria susceptibility in vulnerable populations, which could significantly inform vaccine development. Insights gained may lead to improved public health strategies and interventions targeting malaria in pregnant women and young children.
What changed
Trial Update
Analysis
A longitudinal study will enroll up to 2000 pregnant women and their infants, and 2000 children aged 0-3 years to investigate malaria susceptibility.
This study is critical as it aims to uncover factors influencing malaria susceptibility in vulnerable populations, which could significantly inform vaccine development. Insights gained may lead to improved public health strategies and interventions targeting malaria in pregnant women and young children.
Monitor results from the study regarding immunologic responses and the impact of pregnancy malaria on childhood outcomes.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.